Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Elekta AB (EKTAY) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Elekta AB (EKTAY) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 24th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Compass (COMP - Free Report) provides an end-to-end platform for residential real estate agents to deliver service to seller and buyer clients. The Zacks Consensus Estimate for its current year earnings has been revised almost 20% downward over the last 60 days.
Elekta (EKTAY - Free Report) is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. The Zacks Consensus Estimate for its current year earnings has been revised 19.1% downward over the last 60 days.
Bausch + Lomb (BLCO - Free Report) is an eye health company with product portfolio which includes Biotrue and renu multi-purpose solutions, Biotrue ONEday daily disposable contact lenses, LUMIFY redness reliever eye drops, PreserVision AREDS 2 formula eye vitamin and mineral supplements and VYZULTA. The Zacks Consensus Estimate for its current year earnings has been revised 6% downward over the last 60 days.
View the entire Zacks Rank #5 List.